Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Search PHGKB:

Last Posted: Aug 22, 2023
spot light Highlights

Will a new wave of RSV vaccines stop the dangerous virus?
Liam Drew et al. Nature 2023 1 (7946) 20

Moderna’s mRNA-based vaccine stimulates the production of a stabilized version of this protein, whereas the Pfizer and GSK vaccines inject synthetic versions of it directly. In trials, their efficacies have been remarkably similar, although Bont expects differences to emerge in their initial protection they offer and the durability of immunity after they are rolled out on a larger scale.

Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.